Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reward | 18 | 2025 | 201 | 5.610 |
Why?
|
| Cocaine-Related Disorders | 8 | 2025 | 36 | 5.070 |
Why?
|
| Motivation | 15 | 2025 | 309 | 3.270 |
Why?
|
| Anhedonia | 7 | 2024 | 12 | 3.150 |
Why?
|
| Substance-Related Disorders | 14 | 2024 | 424 | 3.040 |
Why?
|
| Dextroamphetamine | 8 | 2021 | 108 | 2.710 |
Why?
|
| Cocaine | 5 | 2024 | 77 | 2.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2025 | 120 | 1.910 |
Why?
|
| Emotions | 8 | 2021 | 365 | 1.870 |
Why?
|
| Central Nervous System Stimulants | 5 | 2021 | 223 | 1.850 |
Why?
|
| Hallucinogens | 5 | 2022 | 81 | 1.660 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 7 | 2020 | 73 | 1.360 |
Why?
|
| Decision Making | 7 | 2022 | 680 | 1.330 |
Why?
|
| Behavior Therapy | 2 | 2024 | 93 | 1.320 |
Why?
|
| Social Behavior | 6 | 2014 | 303 | 1.220 |
Why?
|
| Double-Blind Method | 18 | 2022 | 1756 | 1.190 |
Why?
|
| Adult | 47 | 2025 | 27538 | 1.190 |
Why?
|
| Naltrexone | 2 | 2022 | 139 | 1.160 |
Why?
|
| Dopamine | 3 | 2022 | 274 | 1.120 |
Why?
|
| Neuropsychological Tests | 6 | 2020 | 524 | 1.100 |
Why?
|
| Depression | 3 | 2020 | 526 | 1.020 |
Why?
|
| Young Adult | 24 | 2024 | 6630 | 0.970 |
Why?
|
| Cognition | 3 | 2020 | 603 | 0.970 |
Why?
|
| Heart Rate | 10 | 2020 | 502 | 0.920 |
Why?
|
| Psychomotor Performance | 8 | 2022 | 500 | 0.900 |
Why?
|
| Anger | 2 | 2024 | 81 | 0.890 |
Why?
|
| Nicotine | 4 | 2022 | 204 | 0.880 |
Why?
|
| Inflammation | 2 | 2020 | 1024 | 0.840 |
Why?
|
| Healthy Volunteers | 4 | 2018 | 146 | 0.840 |
Why?
|
| Memory, Short-Term | 3 | 2018 | 237 | 0.830 |
Why?
|
| Female | 50 | 2025 | 47893 | 0.800 |
Why?
|
| Male | 49 | 2025 | 43927 | 0.790 |
Why?
|
| Affect | 8 | 2023 | 391 | 0.790 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2013 | 68 | 0.770 |
Why?
|
| Tobacco Use Disorder | 4 | 2024 | 116 | 0.740 |
Why?
|
| Humans | 61 | 2025 | 92339 | 0.740 |
Why?
|
| Adolescent | 22 | 2024 | 9495 | 0.730 |
Why?
|
| Cannabis | 1 | 2022 | 35 | 0.730 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2011 | 43 | 0.720 |
Why?
|
| Pleasure | 4 | 2023 | 14 | 0.680 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 91 | 0.660 |
Why?
|
| Intelligence | 2 | 2018 | 71 | 0.660 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2021 | 1939 | 0.650 |
Why?
|
| Dronabinol | 2 | 2022 | 58 | 0.630 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 19 | 0.610 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 146 | 0.580 |
Why?
|
| Appetitive Behavior | 1 | 2018 | 15 | 0.580 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 37 | 0.570 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 72 | 0.560 |
Why?
|
| Cues | 6 | 2022 | 178 | 0.550 |
Why?
|
| Smoking | 7 | 2012 | 640 | 0.530 |
Why?
|
| Schizophrenia | 1 | 2020 | 501 | 0.530 |
Why?
|
| Stress, Psychological | 5 | 2020 | 329 | 0.520 |
Why?
|
| Cytokines | 1 | 2020 | 843 | 0.520 |
Why?
|
| Dopamine Agents | 1 | 2016 | 29 | 0.510 |
Why?
|
| Levodopa | 1 | 2016 | 38 | 0.510 |
Why?
|
| Speech | 2 | 2020 | 88 | 0.490 |
Why?
|
| Facial Recognition | 1 | 2016 | 17 | 0.490 |
Why?
|
| Drug Tolerance | 1 | 2015 | 64 | 0.490 |
Why?
|
| Motor Activity | 1 | 2018 | 330 | 0.490 |
Why?
|
| Ethanol | 2 | 2015 | 262 | 0.470 |
Why?
|
| Social Perception | 1 | 2016 | 94 | 0.470 |
Why?
|
| Attention | 2 | 2018 | 403 | 0.470 |
Why?
|
| Exercise | 1 | 2018 | 335 | 0.460 |
Why?
|
| Euphoria | 2 | 2011 | 43 | 0.460 |
Why?
|
| Middle Aged | 19 | 2025 | 27043 | 0.450 |
Why?
|
| Photic Stimulation | 5 | 2018 | 505 | 0.440 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 165 | 0.440 |
Why?
|
| Oxycodone | 1 | 2014 | 35 | 0.430 |
Why?
|
| Frontal Lobe | 1 | 2014 | 130 | 0.420 |
Why?
|
| Basal Ganglia | 1 | 2013 | 46 | 0.410 |
Why?
|
| Blood Pressure | 6 | 2016 | 907 | 0.410 |
Why?
|
| Firefighters | 2 | 2023 | 2 | 0.400 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 179 | 0.400 |
Why?
|
| Amygdala | 1 | 2013 | 87 | 0.400 |
Why?
|
| Trust | 1 | 2013 | 98 | 0.390 |
Why?
|
| Verbal Behavior | 1 | 2012 | 32 | 0.380 |
Why?
|
| Empathy | 1 | 2014 | 153 | 0.380 |
Why?
|
| Executive Function | 1 | 2012 | 99 | 0.370 |
Why?
|
| Alcoholism | 2 | 2024 | 185 | 0.370 |
Why?
|
| Genotype | 3 | 2013 | 1865 | 0.370 |
Why?
|
| Facial Expression | 1 | 2012 | 56 | 0.370 |
Why?
|
| Caffeine | 1 | 2012 | 84 | 0.360 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 295 | 0.360 |
Why?
|
| Amphetamine | 1 | 2012 | 104 | 0.350 |
Why?
|
| Affective Symptoms | 1 | 2010 | 52 | 0.330 |
Why?
|
| Unsafe Sex | 1 | 2010 | 45 | 0.330 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 471 | 0.320 |
Why?
|
| Psychological Tests | 3 | 2016 | 91 | 0.310 |
Why?
|
| Autonomic Nervous System | 3 | 2020 | 66 | 0.310 |
Why?
|
| Language | 2 | 2020 | 158 | 0.300 |
Why?
|
| Smoking Cessation | 2 | 2011 | 265 | 0.290 |
Why?
|
| Gambling | 2 | 2010 | 166 | 0.280 |
Why?
|
| Self Report | 5 | 2022 | 307 | 0.260 |
Why?
|
| Behavior, Addictive | 2 | 2024 | 136 | 0.240 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 278 | 0.240 |
Why?
|
| Individuality | 3 | 2016 | 111 | 0.230 |
Why?
|
| Bayes Theorem | 2 | 2023 | 390 | 0.220 |
Why?
|
| Tobacco Use | 1 | 2024 | 28 | 0.220 |
Why?
|
| HIV Infections | 2 | 2010 | 896 | 0.220 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2023 | 5 | 0.210 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 306 | 0.210 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 17 | 0.200 |
Why?
|
| Reaction Time | 3 | 2015 | 315 | 0.190 |
Why?
|
| Craving | 2 | 2021 | 23 | 0.190 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 11 | 0.190 |
Why?
|
| Facial Muscles | 2 | 2012 | 24 | 0.190 |
Why?
|
| Mindfulness | 1 | 2021 | 16 | 0.180 |
Why?
|
| Recreation | 1 | 2021 | 8 | 0.180 |
Why?
|
| Sex Characteristics | 3 | 2013 | 331 | 0.180 |
Why?
|
| Comorbidity | 1 | 2025 | 986 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 171 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1920 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1761 | 0.170 |
Why?
|
| Laboratories | 1 | 2020 | 44 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 902 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 37 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 80 | 0.160 |
Why?
|
| Personality | 2 | 2011 | 139 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2793 | 0.150 |
Why?
|
| Galvanic Skin Response | 1 | 2018 | 12 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2015 | 2729 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2018 | 50 | 0.140 |
Why?
|
| Hunger | 1 | 2018 | 23 | 0.140 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1724 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 351 | 0.140 |
Why?
|
| Psychophysics | 1 | 2018 | 80 | 0.140 |
Why?
|
| Oxytocin | 2 | 2020 | 74 | 0.140 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 110 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1774 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 2449 | 0.140 |
Why?
|
| Arousal | 1 | 2018 | 171 | 0.140 |
Why?
|
| Marijuana Abuse | 2 | 2015 | 29 | 0.140 |
Why?
|
| Electromyography | 1 | 2018 | 191 | 0.140 |
Why?
|
| Aged | 4 | 2024 | 19951 | 0.130 |
Why?
|
| Social Environment | 1 | 2018 | 187 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 498 | 0.130 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 10 | 0.130 |
Why?
|
| Games, Experimental | 2 | 2013 | 11 | 0.130 |
Why?
|
| Attentional Bias | 1 | 2015 | 9 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2018 | 497 | 0.120 |
Why?
|
| Machine Learning | 1 | 2018 | 298 | 0.120 |
Why?
|
| Drug Users | 1 | 2015 | 26 | 0.120 |
Why?
|
| Personality Inventory | 1 | 2015 | 109 | 0.120 |
Why?
|
| Computational Biology | 1 | 2018 | 568 | 0.120 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2014 | 9 | 0.110 |
Why?
|
| Gene Expression | 1 | 2018 | 1315 | 0.110 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 290 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 5429 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1901 | 0.110 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 31 | 0.100 |
Why?
|
| Signal Detection, Psychological | 1 | 2013 | 20 | 0.100 |
Why?
|
| United States | 2 | 2024 | 7348 | 0.100 |
Why?
|
| Animals | 2 | 2024 | 28053 | 0.100 |
Why?
|
| Hydrocortisone | 2 | 2012 | 304 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1733 | 0.100 |
Why?
|
| Homozygote | 1 | 2012 | 201 | 0.100 |
Why?
|
| Sensory Thresholds | 1 | 2012 | 57 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3514 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 165 | 0.090 |
Why?
|
| Word Association Tests | 1 | 2011 | 5 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 193 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2012 | 288 | 0.090 |
Why?
|
| Writing | 1 | 2011 | 29 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 47 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2011 | 117 | 0.090 |
Why?
|
| Probability | 1 | 2011 | 357 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2014 | 580 | 0.090 |
Why?
|
| Visual Perception | 1 | 2014 | 330 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2011 | 161 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 1 | 2012 | 159 | 0.090 |
Why?
|
| Stroop Test | 1 | 2010 | 10 | 0.080 |
Why?
|
| Intelligence Tests | 1 | 2010 | 38 | 0.080 |
Why?
|
| HIV Seropositivity | 1 | 2010 | 52 | 0.080 |
Why?
|
| Saliva | 1 | 2011 | 126 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2010 | 245 | 0.080 |
Why?
|
| Alleles | 1 | 2013 | 1142 | 0.080 |
Why?
|
| Memory | 1 | 2011 | 223 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 374 | 0.080 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 220 | 0.080 |
Why?
|
| DNA Repeat Expansion | 1 | 2007 | 4 | 0.070 |
Why?
|
| Anxiety | 1 | 2010 | 324 | 0.070 |
Why?
|
| Placebos | 3 | 2013 | 211 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1180 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 609 | 0.070 |
Why?
|
| Ataxia | 1 | 2007 | 43 | 0.070 |
Why?
|
| Communication | 1 | 2011 | 462 | 0.070 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 139 | 0.070 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 74 | 0.070 |
Why?
|
| Object Attachment | 1 | 2006 | 19 | 0.070 |
Why?
|
| Learning | 1 | 2009 | 295 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2013 | 2978 | 0.060 |
Why?
|
| Universities | 1 | 2006 | 148 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 2368 | 0.060 |
Why?
|
| Students | 1 | 2006 | 174 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2018 | 507 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 736 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 391 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 169 | 0.050 |
Why?
|
| Smokers | 1 | 2021 | 50 | 0.040 |
Why?
|
| Breath Tests | 2 | 2011 | 58 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 449 | 0.040 |
Why?
|
| Psycholinguistics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2016 | 899 | 0.040 |
Why?
|
| Self Concept | 2 | 2013 | 135 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2021 | 191 | 0.040 |
Why?
|
| Semantics | 1 | 2020 | 49 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 1847 | 0.040 |
Why?
|
| Carbon Monoxide | 2 | 2010 | 93 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 584 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 228 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8730 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 189 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 69 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 164 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 379 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 8 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2012 | 46 | 0.020 |
Why?
|
| Linear Models | 1 | 2014 | 427 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2014 | 163 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2355 | 0.020 |
Why?
|
| Introns | 1 | 2012 | 302 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 4471 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 786 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 37 | 0.020 |
Why?
|
| Forecasting | 1 | 2011 | 311 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1117 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 234 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 969 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1505 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 531 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 2502 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 868 | 0.020 |
Why?
|
| Pedigree | 1 | 2007 | 966 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 696 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2006 | 221 | 0.010 |
Why?
|
| Chicago | 1 | 2006 | 1463 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5706 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6920 | 0.010 |
Why?
|